| 摘要 |
<p>The invention relates generally to G protein coupled receptors (GPCRs) and in particular to GPCR agonists and antagonist, use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with GPCRs, such as in treating conditions in which chemokine receptors play a role, e.g., sepsis, arthritis, inflammation and autoimmune diseases,</p> |
